The paradigm of stains: will the lower cost of generics translate into health gains?
Seabra-Gomes
Ricardo
R
D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D003365:Costs and Cost Analysis; D016568:Drugs, Generic / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy
D016568:Drugs, Generic; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors